January 24, 2018 - Research Collaboration between the San Francisco VA, UCSF and CalciMedica, Inc. to Present Results on CRAC Channel Inhibitors in a Stroke Model at International Conference Read More

January 19, 2018 - ViaCyte to Present at Three Upcoming Healthcare Events Read More

January 8, 2018 - Metavention, Inc., Closes $65 Million in Series C Funding, Appoints New Chief Executive Officer Read More

January 5, 2018 - ViaCyte Announces First Patients Implanted in Cohort 2 with Potentially Efficacious Dose of PEC-Direct Islet Cell Replacement Therapy Read More

December 15, 2017 - CIRM Grants ViaCyte $1.4M to Create Immune-Evasive Pluripotent Stem Cell Lines Read More

December 6, 2017 - ViaCyte Selected as a Winner of CONNECT’s 30th Annual Most Innovative New Product Awards Read More

November 17, 2017 - Diazon Pharmaceutical’s anti-cancer agent DZ-2384 mechanism for high activity and low neurotoxicity published by McGill researchers in Science Translational Medicine Read More

November 15, 2017 - DalCor Pharmaceuticals Appoints Dr. Fouzia Laghrissi-Thode to the Board of Directors Read More

November 8, 2017 - Lineagen, Inc. Named to MountainWest Capital Network’s 2017 Utah 100 Read More

October 4, 2017 - ViaCyte to Present at Upcoming Investor & Partnering Events in October Read More